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Introduction:  Persistent  postural-perceptual  dizziness  is  the  dizziness  that  lasts  for  over  three
months with  no  clinical  explanation  for  its  persistence.  The  patient’s  motor  response  pattern
presents changes  and  most  patients  manifest  signiﬁcant  anxiety.
Objective:  To  evaluate  the  clinical  characteristics  of  patients  with  persistent  postural  and
perceptual  dizziness.
Methods:  statistical  analysis  of  clinical  aspects  of  patients  with  persistent  postural-perceptual
dizziness.
Results: 81  patients,  average  age:  50.06  ±  12.16  years;  female/male  ratio:  5.7/1;  main  rea-
sons for  dizziness:  visual  stimuli  (74%),  body  movements  (52%),  and  sleep  deprivation  (38%).
The most  prevalent  comorbidities  were  hypercholesterolemia  (31%),  migraine  headaches  (26%),
carbohydrate  metabolism  disorders  (22%)  and  cervical  syndrome  (21%).  DHI,  State-Trait  Anxiety
Inventory  --  Trait,  Beck  Depression  Inventory,  and  Hospital  Anxiety  and  Depression  Scale  ques-
tionnaires were  statistically  different  (p  <  0.05)  when  compared  to  controls.  68%  demonstrated
clinical improvement  after  treatment  with  serotonin  reuptake  inhibitors.
Conclusion:  Persistent  postural-perceptual  dizziness  affects  more  women  than  men,  with  a  high
associated  prevalence  of  metabolic  disorders  and  migraine.  Questionnaires  help  to  identify  the
predisposition  to  persistent  postural-perceptual  dizziness.  The  prognosis  is  good  with  adequate
treatment.
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Caracterizac¸ão clínica  dos  pacientes  com  tontura  postural-perceptual  persistente
(TPPP)
Resumo
Introduc¸ão:  A  denominac¸ão  tontura  postural-perceptual  persistente  (TPPP)  é  atribuida  à  ton-
tura que  se  mantém  por  mais  de  3  meses  em  pacientes,  sem  que  exista  justiﬁcativa  clínica
para a  sua  persistência.  A  maioria  dos  pacientes  possui  perﬁl  ansioso  ou  experimenta  alto  grau
de ansiedade  no  início  dos  sintomas.  O  padrão  de  resposta  motora  apresenta-se  alterado,  com
hipervigilância  e  hipersensibilidade  a  estímulos  visuais  e  de  movimento.
Objetivo:  Avaliar  as  características  clínicas  de  pacientes  com  diagnóstico  de  TPPP.
Método: Análise  dos  aspectos  clínicos  de  pacientes  do  ambulatório  de  TPPPe  quantiﬁcac¸ão  do
perﬁl ansioso  ou  depressivo.
Resultados:  Foram  avaliados  81  pacientes,  com  média  de  idade  de  50,06  ±  12,16  anos;  relac¸ão
mulher/homem  de  5,7/1;  principais  gatilhos  para  tontura:  estímulos  visuais  (74%),  movimentos
corporais  (52%)  e  privac¸ão  de  sono  (38%).  As  comorbidades  mais  prevalentes  foram  hipercoles-
terolemia (31%),  migrânea  (26%),  distúrbios  do  metabolismo  do  ac¸úcar  (22%)  e  síndrome  cervical
(21%). Os  questionários  DHI,  STAI-Trac¸o,  Beck  para  depressão  e  HADS  foram  estatisticamente
diferentes  (P  <  0,05)  entre  pacientes  e  controles.  68%  de  melhora  clínica  com  o  uso  de  inibidores
da recaptac¸ão  da  serotonina.
Conclusão:  TPPP  acomete  principalmente  as  mulheres,  sendo  alta  a  associac¸ão  com  distúrbios
metabólicos  e  migrânea.  Os  questionários  auxiliam  na  identiﬁcac¸ão  da  predisposic¸ão  à  TPPP.
Há bom  prognóstico  com  o  tratamento  adequado.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por



























severity  of  the  initial  imbalance  and  to  the  anxiety  gener-Introduction
The  ﬁeld  of  Otoneurology  evolved  considerably  in  recent
decades,  from  a  simple  vestibulometric  evaluation  of  the
vestibule-ocular  reﬂex  to  a  complex  investigation  of  balance
and  posture.  Nevertheless,  there  are  patients  who  exhibit
undiagnosed  dizziness  not  explained  by  some  otoneurologic
disease,  even  with  the  help  of  the  full  range  of  diagnostic
tests  offered  today.  The  tests  present  normal  results;  until  a
short  time  ago,  these  patients  were  labeled  as  psychogenic.
Psychiatric  syndromes  also  do  not  explain  the  symptoms
found  in  these  individuals.  In  1986,  Brandt1 described  the
phobic  postural  vertigo  (PPV),  which  still  did  not  explain
in  detail  the  origin  of  symptoms  nor  suggested  any  kind  of
treatment.  At  the  beginning  of  the  21st  century,  Staab  and
Ruckenstein  related  physical  symptoms  of  PPV  to  behavioral
factors,  in  may  2013,  it  was  renamed  persistent  postural  and
perceptual  dizziness  (PPPD)  for  compatibility  with  DSM-5.2,3
PPPD  is  deﬁned  as  a  type  of  dizziness  that  persists  for
over  three  months  with  no  identiﬁable  etiology.3 This  is
a  somatoform  disorder,  representing  an  interface  between
otoneurology  and  psychiatry.  Apparently,  patients  with  PPPD
present  a  proﬁle  that  predisposes  to  the  persistence  of  dizzi-
ness  after  an  event  of  physical  or  emotional  illness.  When
there  is  such  a  proﬁle,  the  postural  stability  maintenance
system  becomes  hyper-reactive  to  movement,  especially  in
environments  with  high  visual  demands.  From  this  sensitiv-
ity,  there  is  an  increase  in  the  risk  of  behavioral  disorders
such  as  anxiety,  phobias,  and  depression.4 Thus,  PPPD
reﬂects  the  persistence  of  a  vigilant  pattern  of  posture
control  that  was  assumed  during  the  acute  phase  of  the
disease.4
a
iPPPD  is  a  chronic  condition  that  can  last  for  months
r  years,5--7 and  is  characterized  by  six  basic  aspects4:  (1)
ersistent  sway  or  instability  not  detectable  on  physical
xamination;  (2)  Worsening  of  symptoms  in  the  standing
osition;  (3)  Worsening  of  symptoms  with  head  movements
r  with  complex  visual  stimuli;  (4)  Presence  of  illness  or  emo-
ional  shock  at  symptom  onset4;  (5)  Concurrent  diseases,
ainly  that  gave  rise  to  the  symptoms7;  (6)  Anxiety.
The  association  between  dizziness  and  anxiety  in
toneurological  patients  is  attributed  to  neural  inter-
ctions  explained  by  neuroanatomy.2 These  interactions
nclude  connections  between  central-vestibular  pathways
nd  neural  networks  of  anxiety  and  fear.  The  functional  neu-
ocircuitry  of  anxiety  includes  the  amygdala,  insula,  anterior
ingulate,  prefrontal  cortex,  superior  frontal  gyrus,  para-
ingulate,  and  inferior  frontal  gyrus.  These  structures  are
losely  linked  to  emotion,  and  their  dysfunction  can  result
n  impaired  neural  processing,  with  consequent  anxiety.8
he  identiﬁcation  of  the  interdependence  between  otoneu-
ologic  and  psychiatric  diseases  becomes  crucial  in  the
rognosis  of  dizziness.9
Based  on  the  concepts  presented  by  Staab  and
uckenstein,9 PPPD  can  produce  three  different  manifesta-
ions:  (1)  Psychogenic:  anxiety  is  the  sole  cause  of  dizziness;
2)  Otogenic:  an  otoneurologic  disease  acts  as  a  trigger  that
ctivates  the  circuitry  of  anxiety;  (3)  Interactive:  an  otoneu-
ologic  disease  triggers  dizziness,  which  in  turn  exacerbates
re-existing  anxiety  symptoms.  There  are  reports  describing
hat  the  persistence  of  dizziness  is  directly  related  to  theted  by  bodily  sensations  during  the  episode.10 The  anxiety
































































































Portuguese  version):22 a  self-report  scale  with  seven  items
for  anxiety  (HADS-A)  and  seven  for  depression  (HADS-D).  The78  
he  therapeutic  approach  to  PPPD  takes  into  account  some
asic  principles.  The  ﬁrst  is  the  correct  identiﬁcation  of  the
ymptoms,  followed  by  counseling  for  good  dietary  habits,
edication,  vestibular  rehabilitation,  and  psychotherapy.
estibular  rehabilitation  is  based  on  the  identiﬁcation  of
roublesome  movements  and  on  the  demonstration  to  the
atient  that  the  fear  of  their  carrying  out  these  movements
s  unfounded;  thus,  the  classical  protocols  of  adaptation  and
ubstitution  do  not  apply.  Cognitive-behavioral  therapy,  per-
ormed  during  a  brief  period,  is  the  psychotherapy  of  choice.
his  treatment  helps  the  patient  to  identify  situations  that
ause  distress,  allowing  the  choice  of  the  most  suitable  reac-
ional  behavior.13 The  use  of  psychometric  testing  aids  in
sychiatric  screening  and  in  the  assessment  of  the  degree
f  perception  of  dizziness-induced  harm.
The  drugs  of  choice  for  this  treatment  are  serotonin
euptake  inhibitors  (SSRIs);  serotonin  is  the  primary  neu-
otransmitter  for  those  previously  described  nuclei.  These
rugs  change  and  regulate  neural  conduction  through  anxi-
ty  circuits  and  central  vestibular  neurons  that  respond  to
ovement.  With  the  proper  use  of  SSRIs,  a  reduction  of
ymptoms  can  be  obtained  in  as  many  as  70%  of  individuals,
n  approximately  three  months  of  treatment.14
The  knowledge  of  the  clinical  features  of  patients  with
PPD  allows  for  the  establishment  of  a  correct  diagnosis  and
n  appropriate  treatment.  This  article  aim  to  describe  the
ain  clinical  features  and  therapeutic  responses  in  outpa-
ients  with  a  diagnosis  of  PPPD.
ethods
his  study  assessed  patients  who  attended  the  PPPD  outpa-
ient  clinic  during  the  year  of  2013.  This  clinic  is  part  of  the
PPD  research  project,  approved  by  the  ethics  committee
f  the  institution  under  number  0411/10.
The  sample  consisted  of  81  patients  between  17  and
0  years  (mean  age  50.06  ±  12.16  years),  12  males  and  55
emales.  All  participants  signed  an  informed  consent  form.
In  order  to  be  included  in  the  PPPD  outpatient  clinic,
he  patient  should  have  experienced  persistent  dizziness
or  over  three  months,  with  no  identiﬁable  causes  for
he  symptomatology,  i.e.,  all  comorbidities  (carbohydrate
etabolic  disorder,  dyslipidemia,  thyroid  disorders,  neck
ain,  heart  disease,  blood  pressure  disorder,  dysautonomia,
analithiasis,  cupulolithiasis,  anemia,  and  other  dizziness-
nducing  disorders)  were  compensated.  All  patients  were
reviously  attended  to  and  treated  by  physicians  at  the  gen-
ral  outpatient  clinic.  All  participants  were  submitted  to  a
ull  oculographic  examination  and  serological  tests;  when
linically  indicated,  the  participants  were  also  submitted
o  a  computerized  rotational  pendulum  test,  computerized
ynamic  posturography,  evoked  potentials  test,  and  imag-
ng  studies.  None  of  the  others  patients  diseases  has  a cause
ffect  relationship  to  the  symptoms  presented.  Then,  the
atients  followed  a  particular  routine  of  investigation  espe-
ially  developed  for  patients  with  PPPD.
The  control  group  consisted  of  patients  whose  dizziness
eased  within  three  months  without  the  use  of  psychotropic
rugs.  Sertraline  at  a  dose  of  25--100  mg/day  was  the  ﬁrst
harmacological  option;  it  was  replaced  by  paroxetine  at
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esponse  after  eight  weeks  of  use  or  due  to  the  emer-
ence  of  side  effects  (increased  anxiety,  sexual  dysfunction,
astrointestinal  or  sleep  disorders).  Patients  were  referred
or  psychotherapy  and  desensitizing,  where  desensitizing
xercises  i.e.,  dizziness-inducing  stimuli  for  a  gradual  and
rogressive  practice  until  tolerance,  were  prescribed.
Patients  were  classiﬁed  as  responders,  when  they
resented  complete  resolution  of  symptoms;  partial  respon-
ers,  when  they  presented  symptomatic  improvement,  but
ith  persistence  of  some  symptoms;  and  non-responders,  if
here  was  no  perception  of  improvement.
The  control  group  consisted  of  only  seven  female  vol-
nteers,  due  to  the  difﬁculty  of  recruiting  asymptomatic
atients;  this  gender  was  chosen  for  being  the  most  preva-
ent  in  the  otoneurology  outpatient  clinic.
The  study  and  control  groups  responded  to  several
sychometric  tests,  all  previously  validated  for  Brazilian  Por-
uguese.
namnesis
uring  the  admission  anamnesis,  ﬁve  key  points  were  evalu-
ted:  time  of  onset  of  symptoms,  symptom  characteristics,
ircumstances  in  which  the  dizziness  occurs,  associated
ymptoms,  underlying  diseases,  and  predisposing  factors  to
izziness.15,16
hysical  examination
he  following  tests  to  investigate  the  oculovestibu-
ar  reﬂexes  were  performed:  spontaneous  and  semi-
pontaneous  nystagmus,  head  shaking  nystagmus,  and  head
mpulse  test.  The  postural  stability  was  then  evaluated  by
omberg,  Fukuda,  and  walking  tests.
uestionnaires
HI  (Brazilian  Portuguese  version):17,18 comprises  25  ques-
ions,  seven  of  which  assess  physical  aspects;  nine  assess
motional  aspects;  and  nine  assess  functional  aspects.  The
aximum  score,  suggesting  a  high  overall  dizziness-induced
amage,  is  100  points.
State-Trait  Anxiety  Inventory  (STAI):19 two  scales  of  self-
ssessment  consisting  of  20  items  each,  ranging  from  1  to  4.
hese  scales  assess  anxiety  as  a  transitory  emotional  state
STAI-E  [state])  or  as  a  permanent  characteristic  of  the  indi-
idual  (STAI-T  [trace]).20
Beck  Depression  Inventory  (BDI):  The  original  scale  con-
ists  of  21  items,  ranging  from  0  to  3  in  terms  of  intensity.20
or  samples  without  a  diagnosis  of  depression,  the  following
ntervals  were  adopted:  <15:  normal;  16--20:  indicative  of
ysphoria;  >20:  indicative  of  depression.21
Hospital  Anxiety  and  Depression  Scale  (HADS)  (Braziliancore  for  each  subscale  ranges  from  0  to  21.  A  score  of  eight
r  more  on  the  subscales  of  anxiety  or  depression,  or  a  total
core  (anxiety  +  depression)  of  12  or  more  suggests  clinically
igniﬁcant  psychiatric  symptoms.22
Chronic  subjective  dizziness  
Table  1  Sample  characterization  in  relation  to  gender  and
age.
Gender  n  Age  (mean  ±  DP)  p
Male  12  49.41  ±  10.43
Female  69  52.32  ±  12.5
Total 81  50.06  ±  12.16  0.41
Table  2  Main  triggers  in  the  onset  of  symptoms  of  persis-
tent postural  and  perceptual  dizziness  no  lugar  de  chronic
subjective  dizziness.
Trigger  n  Percentage
Visual  stimuli  60  74%
Body movements  42  52%
Sleep deprivation  31  38%































bStress 20  25%
Neck 11  14%
Study  variables  and  statistical  analysis
The  clinical  characteristics  of  patients  with  PPPD  are
described  in  Tables  1--5  with  percentages  of  prevalence.  For
the  questionnaires,  comparative  calculations  were  made  by
Student  t-test  for  research  participants,  compared  to  the
control  group,  which  consisted  of  asymptomatic  patients
from  the  general  outpatient  clinic,  with  otoneurologic  dis-
ease  and  a  good  response  to  treatment.
The  level  of  signiﬁcance  was  set  at  5%  (p  =  0.05).
ResultsThe  gender  and  ages  of  the  subjects  in  the  study  sam-
ple  are  shown  in  Table  1.  The  mean  age  of  subjects  was
50.06  ±  12.16  years,  with  no  statistically  signiﬁcant  differ-
ences  between  genders  (p  =  0.41).
Table  3  Comorbidities  associated  to  persistent  perceptual
and  postural  dizziness  no  lugar  de  chronic  subjetive  dizziness
in the  study  group.
Disease  n  Percentage
Hypercholesterolemia  25  31%
Migraine  21  26%
CMD 18  22%
Cervical  syndrome  17  21%
BPPV 12  15%
Dysautonomia  6  7%
Otitis media  6  7%
SAH 4  5%
Cardiac  arrhythmia  4  5%
Diabetes  4  5%
Hypothyroidism  4  5%
Menière’s  syndrome  4  5%
CMD, carbohydrate metabolic disorders (hypoglycemia, intol-
erance, and hyperinsulinemia); BPPV, benign paroxysmal























When  considering  the  type  of  PPPD  according  to  the  crite-
ia  deﬁned  by  Staab  and  Ruckenstein,9 12  patients  were
lassiﬁed  as  psychogenic  PPPD  (14.8%),  20  as  otogenic  PPPD
24.7%),  and  49  as  interactive  PPPD  (60.5%).
The  main  triggers  that  caused  the  abovementioned  symp-
oms  are  described  in  Table  2.  The  three  most  prevalent
timuli  were  visual  stimuli  (74%),  body  movements  (52%),
nd  sleep  deprivation  (38%).  Some  subjects  had  two  or  more
riggers  for  their  symptoms,  with  a  maximum  of  eight.
The  comorbidities  associated  with  PPPD  can  be  observed
n  Table  3.  Major  diseases  associated  with  PPPD  were
ypercholesterolemia  (31%),  migraine  (26%),  carbohydrate
etabolic  disorder  (22%),  cervical  syndrome  (21%),  benign
aroxysmal  positional  vertigo  (15%)  dysautonomia  (7%),  dis-
rders  of  the  middle  ear  (7%),  hypertension  (5%),  cardiac
rrhythmia  (5%),  diabetes  (5%),  hypothyroidism  (5%),  and
enière’s  syndrome  (5%).  In  addition  to  the  described
omorbidities,  the  following  were  found,  accounting  for
ess  than  2%  of  prevalence:  elderly  unbalance  syndrome,
eripheral  facial  palsy,  vestibular  neuritis,  epilepsy,  sudden
eafness,  hepatitis  C.  Some  patients  had  more  than  one
omorbidity  associated  with  PPPD,  with  a  maximum  of  six
or  this  sample.
Regarding  the  formulated  questionnaires,  only  STAI-E
p  =  0.36)  showed  no  signiﬁcant  difference  between  patients
ith  a  diagnosis  of  PPPD  and  those  with  no  chroniﬁed
izziness  after  the  vestibular  event.  All  other  question-
aires  showed  signiﬁcant  differences  among  the  groups:
HI  (p  =  0.008),  STAI-T  (p  =  0.0008),  BDI  (p  =  0.0005),  HADS-A
p  =  0.0001),  and  HADS-D  (p  =  0.0007).  The  mean  responses
btained  from  the  questionnaires  are  described  in  Table  4.
Regarding  the  evaluation  of  responses  to  pharmacological
reatment  with  SSRIs,  the  results  can  be  seen  in  Table  5.
f  the  45  treated  patients,  46%  responded  satisfactorily  to
edication,  22%  had  partial  response,  and  31%  exhibited  no
eneﬁt.
iscussion
PPD  is  a  relatively  new  diagnosis  that  involves  the
estibular-thalamic  pathways,  responsible  for  body  move-
ent  awareness.23,24 The  predisposition  to  sensitivity  of
he  structures  involved  in  the  connections  between  the
estibular-thalamic  pathways  and  the  circuitry  responsible
or  anxiety  and  fear  determine  symptom  onset.  This  disease
s  at  the  interface  between  otoneurology  and  psychiatry,  and
he  patient  has  normal  vestibular  reﬂexes,  while  maintain-
ng  a  vigilant  pattern  of  postural  control.  This  is  a  highly
istressing  condition  for  the  patient,  who  will  seek  multiple
hysicians  and  will  be  submitted  to  several  tests  without
nding  answers  to  his/her  symptoms.
The  mean  age  of  the  study  group  did  not  differ  from  the
ecent  literature.25 In  the  present  sample,  the  mean  age  did
ot  differ  between  genders,  but  comprised  a  higher  number
f  females,  at  a proportion  of  5.7:1.  Recent  population  sur-
ey  in  the  city  of  São  Paulo  conﬁrms  the  high  prevalence  of
izziness  in  females,  in  a  ratio  of  1.67:1,  especially  in  the
ge  group  between  46  and  55  years.26 The  higher  prevalence
f  females  is  attributed  to  hormonal  changes.  It  is  interest-
ng  to  note  that,  at  the  age  group  between  the  fourth  and
fth  decades  of  life,  the  female  climacteric  occurs,  with
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Table  4  Responses  to  questionnaires  formulated  for  patients  with  chronic  subjective  dizziness  (study  group)  and  patients  who
did not  exhibited  croniﬁcation  of  their  dizziness  after  a  vestibular  event  (control  group).
Questionnaire  Study  group  (mean  scoring)  Control  group  (mean  scoring)  p
DHI  52.66  ±  21.74  13.66  ±  24.11  0.008a
STAI-T  52  ±  10.19  32.85  ±  9.44  0.0008a
STAI-E  38.66  ±  11.80  33.71  ±  11.49  0.36
BDI 14.57  ±  8.14  4.28  ±  3.14  0.0005a
HADS-A  12.57  ±  3.32  3.16  ±  3.12  0.0001a
HADS-D  7.71  ±  4.42 1.8  ±  2.22 0.0007a
STAI-T, State-Trait Anxiety Inventory -- Trait; STAI-E, State-Trait Anxiety Inventory -- State; BDI, Beck Depression Inventory; HADS-A,
Hospital Anxiety and Depression Scale -- Anxiety; HADS-D, Hospital Anx
a Statistically signiﬁcant difference between groups.
peaks  of  migraine.27,28 Staab  and  Ruckenstein  also  observed
a  female  dominance,  with  a  ratio  of  2:1.29 Due  to  the  higher
prevalence  of  PPPD  in  women,  the  outpatient  clinic  was  ini-
tially  only  for  women.  The  authors  believe  that  the  higher
number  of  women  in  relation  to  literature  data  occurred
because,  for  institutional  reasons,  this  particular  outpatient
clinic  admitted  only  women  at  the  beginning  of  its  opera-
tion.
According  to  the  descriptions  of  Staab,9 PPPD  can  be
divided  into  three  types:  interactive,  otogenic,  or  psy-
chogenic.  In  the  present  sample,  60.5%  of  patients  were
classiﬁed  as  interactive,  24.7%  as  otogenic,  and  only  14.8%
as  psychogenic  CSD.  These  data  suggest  that  approximately
75%  (60.5  +  14.8)  of  the  present  patients  had  a  typically  anx-
ious  proﬁle  before  developing  their  symptoms.  Staab  and
Ruckenstein  also  reported  a  high  prevalence  of  anxiety  dis-
orders  in  60%  of  their  patients  with  PPPD.29 Panic  disorder
prevailed  in  patients  with  psychogenic  form,  whereas  gen-
eralized  anxiety  disorder  was  more  common  in  interactive
PPPD,  and  mild  anxiety  symptoms  were  more  common  in
the  otogenic  form.29 These  observations  highlight  the  need
for  psychiatric  support  for  these  patients.  The  partnership
between  psychiatry  and  otoneurology  becomes  critical  for  a
good  treatment  of  patients  who  present  anomalous  neural
transmission  of  connections  between  the  vestibular  path-
ways  and  the  circuitry  of  vigilance  and  fear.
Regarding  the  triggers  for  PPPD  crisis,  visual  stimuli  was
observed  as  a  trigger  in  74%  of  individuals,  comprising  the
26%  of  subjects  who  reported  symptoms  when  in  crowded
places.  These  patients  appear  to  present  visual  dependency
and  a  tendency  to  rely  more  on  visual  cues  than  in  vestibular
and  somatosensory  afferents  for  the  maintenance  of  their
posture.  For  reasons  still  unknown,  anxious  patients  often
develop  visual  dependency.12 The  second  trigger,  in  order  of
frequency,  are  body  movements,  as  described  in  the  litera-
ture.  The  high  level  of  anxiety  experienced  by  these  patients
Table  5  Response  of  patients  with  a  diagnosis  of  chronic
subjective  dizziness  pharmacologically  treated  with  SSRIs.
Response  to  SSRIs  n  Percentage
Yes  21  46%
Partial 10  22%
No 14  31%













































iiety and Depression Scale -- Depression.
ead  to  an  elevated  muscle  tension  and  stiffness  in  the  neck,
o  avoid  movements  that  cause  the  uncomfortable  sensa-
ions  of  instability  and  fear.30 From  this  perspective,  it  is
asy  to  understand  the  high  prevalence  of  cervical  syndrome
21%)  and  neck  pain  as  a  trigger  for  their  symptoms.  An
nteresting  fact  is  sleep  deprivation,  functioning  as  a  trig-
er  for  the  symptoms  of  PPPD  in  38%  of  cases,  together
ith  stress  in  25%  of  them.  Stress  acts  as  a  trigger  for  sen-
itizing  the  neural  pathways  responsible  for  the  reactions
f  vigilance.  As  previously  mentioned,  PPPD  mainly  affects
omen  between  the  fourth  and  ﬁfth  decades  of  life,  at  the
limacteric  time,  which  is  the  peak  incidence  of  migraine.
he  main  triggers  of  PPPD  are  exactly  the  same  as  those  for
igraine  attacks:  visual  conﬂict,  head  movements,  stress,
leep  deprivation.27,28 The  similarity  of  symptoms  raises  the
uestion  of  whether  there  is  an  interdependence  between
PPD,  migraine,  and  metabolic  and  hormonal  dysfunction.
n  fact,  the  three  most  frequent  comorbidities  in  patients
ith  PPPD  are  dyslipidemia  (31%),  migraine  (26%),  and  car-
ohydrate  metabolic  disorders  (22%).  Staab  and  Ruckenstein
bserved  a  prevalence  of  16.5%  of  migraine  in  patients  with
PPD.29
Regarding  DHI,  the  mean  score  from  patients  in  this
tudy  (52.66  ±  21.74)  did  not  differ  from  the  recent  liter-
ture  (59.8  ±  19.3).  Patients  with  PPPD  had  a  higher  score
hen  compared  to  the  control  group  (p  =  0.008).  This  ﬁg-
re  allows  for  the  conclusion  that,  compared  to  control
ubjects,  the  presented  symptoms  compromise  the  self-
erception  of  body  balance  and  interfere  with  the  quality  of
ife  of  these  patients.31 For  questions  relating  to  STAI  ques-
ionnaire,  no  signiﬁcant  difference  between  groups  in  the
TAI-E,  which  reproduces  the  state  of  anxiety  at  the  time
f  consultation,  was  observed  (p  =  0.36).  However,  when
valuating  STAI-T,  it  was  noted  that  the  PPPD  group  pre-
ented  a  signiﬁcant  difference  when  compared  to  controls
p  =  0.0008).  Gorestein  and  Andrade20 classiﬁed  STAI  scores
33  as  low;  between  33  and  49,  moderate;  and  >49,  high.
agger  et  al.32 observed  a STAI-E  value  of  43.5  ±  8.9  and
 STAI-T  of  40.4  ±  9.7,  with  no  differences  between  symp-
omatic  and  asymptomatic  subjects.  In  the  present  study,
he  STAI  questionnaires  scores  were  38.66  ±  11.8  for  STAI-
 and  52  ±  10.19  for  STAI-T,  with  a  statistically  signiﬁcant
ifference  when  compared  to  controls  only  in  STAI-T  scale.
hus,  the  present  sample  had  a  mean  STAI  with  high  scores
n  both  questionnaires,  but  mainly  in  STAI-T.  It can  be
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anxious  during  their  clinical  visit,  but  do  exhibit  anxiety  as
a  characteristic  trait  of  their  personality.  The  anxiety  pat-
tern  affects  the  assessment  of  postural  challenges,  and  the
patient  assumes  high-risk  control  strategies  for  movements
of  low  demand,  changing  their  gait  and  posture  because
of  his/her  hypervigilance.  The  higher  the  anxiety  trait,  the
greater  the  fear  of  postural  challenges  and  the  more  exag-
gerated  the  corrective  strategies.14
The  BDI  reﬂects  the  degree  of  depression  in  the  patient
evaluated.  A  score  of  15  points  on  the  scale  is  considered
normal,  and  patients  who  score  between  16  and  20  points
are  considered  as  dysphoric  (i.e.,  with  a  decreased  level
of  humor,  but  not  depression).  In  the  present  sample,  a
signiﬁcant  difference  was  observed  between  PPPD  and  con-
trol  groups  (p  =  0.0005).  The  average  for  the  PPPD  group
(14.57  ±  8.14)  characterized  most  subjects  as  normal,  but
the  high  standard  deviation  of  the  sample  shows  that  there
is  a  greater  tendency  for  a  depressed  mood  in  patients,  when
compared  to  controls.20
Regarding  HADS,  the  present  results  are  in  agreement
with  those  in  the  literature.  Staab  et  al.  found  an  average
of  10.9  ±  3  for  HADS-A  and  of  8.1  ±  4.4  for  HADS-D.25 The
present  sample  had  an  average  score  of  12.57  ±  3.32  (nor-
mal  <8)  for  HADS-A  and  7.71  ±  4.42  (normal  <8)  for  HADS-D.
Both  responses  differ  signiﬁcantly  from  the  control  group
(p  =  0.0001  and  p  =  0.0007,  respectively),  demonstrating  that
PPPD  patients  have  changes  within  the  anxiety  and  depres-
sion  area,  compared  to  the  asymptomatic  population.  These
values,  however,  do  not  characterize  individuals  with  PPPD
as  depressive,  since  the  scoring  for  depression  is  borderline.
However,  the  HADS-A  was  higher,  just  a  little  above  the  limit
accepted  for  normality,  again  characterizing  these  patients
as  anxious.
According  to  literature,  the  response  to  SSRIs  stays
around  70%  to  75%.14,33 The  present  data  do  not  differ  from
published  reports,  and  the  treatment  produces  satisfactory
results  in  46%  of  patients,  with  partial  results  in  22%  of  them.
The  sum  of  the  positive  responses  reached  68%  --  a  spectrum
expected  for  the  population  of  patients  with  PPPD.
Finally,  the  present  experience  with  patients  of  PPPD
show  features  very  close  to  the  international  literature
reports,  and  brings  to  light  many  aspects  still  little  known
to  otorhinolaryngologists.  Since  this  is  a  group  of  somato-
form  patients,  the  association  between  somatic  and  psychic
evaluation  is  crucial  for  a  better  resolution  of  the  symptoms.
Conclusion
PPPD  is  a  dysfunction  generated  by  psychic  and  somatic
interactions,  which  affects  more  women  in  the  menopausal
age  group,  with  high  association  with  metabolic  disorders
and  migraine.  The  main  triggers  of  PPPD  are  visual  con-
ﬂict,  head  movements,  stress,  and  sleep  deprivation.  The
questionnaires  help  in  the  identiﬁcation  of  predisposition  to
this  disease.  An  adequate  therapy  confers  to  PPPD  a  good
prognosis,  with  improvements  observed  in  almost  70%  of
patients.Funding
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